Abstracts Archive - Page 2415 of 2605 - ACR Meeting Abstracts

Abstract Number: 202 • 2013 ACR/ARHP Annual Meeting
Analysis Of Non-Steroidal Anti-Inflammatory Drug Burden Among Rheumatoid Arthritis Patients Using The Dougados Algorithm
E Alemao¹, L Xie², R Wong¹, G Lltalien¹ and O Baser³, ¹Bristol-Myers Squibb, Princeton, NJ, ²SATinMED Research, Ann Arbor, MI, ³STATinMED Research and University of Michigan, Ann Arbor, MI
Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are used to alleviate RA pain symptoms, but they may be associated with adverse events. Previous studies examining clinical and…
Abstract Number: 203 • 2013 ACR/ARHP Annual Meeting
Belief In Self-Adjustability Of Medication Dosing Is Negatively Correlated With Medication Adherence In Patients With Rheumatoid Arthritis
Wenxin Sun¹, Dianne Carrol Tan Bautista², Xiaohui Xin³, Yu Ting Saw³, Wee Boon Tan³, Kanchanadevi Balasubramaniam³, Wan Pin Lee⁴, Steve Thein Htay Oo³, Yin Bun Cheung² and Julian Thumboo⁵, ¹Duke-NUS Graduate Medical School, Singapore, Singapore, ²Center for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore, ³Academic Clinical Programme, Division of Medicine, Singapore General Hospital, Singapore, Singapore, ⁴Operation and Performance Management, Singapore General Hospital, Singapore, Singapore, ⁵Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore
Background/Purpose: Medication adherence in Rheumatoid Arthritis (RA) is reported to be generally low. This major problem needs to be addressed because it leads to reduced…
Abstract Number: 204 • 2013 ACR/ARHP Annual Meeting
Evaluation Of Hospitalizations and Costs In Patients With Rheumatoid Arthritis In United States Medicare Population
E Alemao¹, L Wang², G Lltalien¹, O Baser³, H Yuce⁴ and M Hochberg⁵, ¹Bristol-Myers Squibb, Princeton, NJ, ²STATinMED Research, Dallas, TX, ³STATinMED Research and University of Michigan, Ann Arbor, MI, ⁴New York City College of Technology (CUNY), Brooklyn, NJ, ⁵University of Maryland, Baltimore, MD
Background/Purpose: RA-related hospitalization and surgery (e.g. total joint arthroplasty [TJA]) are important long-term outcomes in RA. While advances in treatment for RA have resulted in…
Abstract Number: 205 • 2013 ACR/ARHP Annual Meeting
Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines
Gemma L Wallace¹, C. J. Edwards², Nigel K. Arden³, Daniel Prieto-Alhambra⁴ and Andrew Judge⁵, ¹NDORMS, University of Oxford, Oxford, United Kingdom, ²Rheumatology, University Hospital Southampton, Southampton, United Kingdom, ³NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, ⁴Internal Medicine; Primary Care; NDORMS Dept; MRC Lifecourse Epidemiology Unit, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol; University of Oxford; University of Southampton, Barcelona, Spain, ⁵Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom
Background/Purpose: Disease modifying anti-rheumatic drugs (DMARDs) are standard initial treatments for rheumatoid arthritis (RA). Many RA treatment guidelines have been published including from the American…
Abstract Number: 206 • 2013 ACR/ARHP Annual Meeting
American College Of Rheumatology’s Rheumatology Informatics System For Effectiveness Registry Pilot
Peter J. Embi¹, William Stephens² and Rachel Myslinski³, ¹Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, ²College of Medicine, Ohio State University, Columbus, OH, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA
Background/Purpose: There is a significant need in the rheumatology community to access and integrate data across diverse patient populations in order to aid quality improvement…
Abstract Number: 207 • 2013 ACR/ARHP Annual Meeting
Frequency and Predictors Of Hypertension Communication In Rheumatoid Arthritis Visits
Christie M. Bartels¹, Heather Johnson², Elizabeth A. Jacobs³, Patrick McBride² and Maureen Smith⁴, ¹Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Department of Medicine, General Internal Medicine Division, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Patients with rheumatoid arthritis (RA) have a 60% higher cardiovascular disease (CVD) event risk, yet previously we demonstrated they were ~30% less likely to…
Abstract Number: 208 • 2013 ACR/ARHP Annual Meeting
Three Approaches To Evaluating Step Therapy Policies For Immune Disorder Specialty Pharmaceuticals
Michael P. Ingham¹, Andrew Paris², Lorie A. Ellis³ and Chris Kozma⁴, ¹Janssen Scientific Affairs, LLC, Horsham, PA, ²Vigilytics, Victor, NY, ³Health Economics & Outcomes Research, Janssen Scientific Affairs, LLC, Horsham, PA, ⁴CK Consulting, Saint Helena Island, SC
Background/Purpose: Rheumatology practices are increasingly exposed to patient health care benefit plans that include “step therapy” (ST) policies which affect medication choice. Managed care companies…
Abstract Number: 209 • 2013 ACR/ARHP Annual Meeting
Focus on cardiovascular Risk Factor Recording In a Rheumatology Outpatient Clinic
Eirik Ikdahl¹, Silvia Rollefstad², Inge C. Olsen³, Tore K. Kvien⁴, Inger Johanne Widding Hansen⁵, Dag Magnar Soldal⁶, Glenn Haugeberg⁶ and Anne Grete Semb⁷, ¹Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, ³Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Faculty of Medicine, University of Oslo, Oslo, Norway, ⁵Hospital of Southern Norway Trust, Kristiansand, Norway, Kristiansand, Norway, ⁶Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, ⁷Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: There is an unmet need of implementing the knowledge of cardiovascular (CV) risk in patients with rheumatoid arthritis (RA) into clinical practice. Our aim…
Abstract Number: 210 • 2013 ACR/ARHP Annual Meeting
Medication Adherence In Patients With Gout: A Systematic Review
Mary De Vera^1,2, Sharan Rai¹ and Vidula Bhole³, ¹Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ³EpiSolutions Consultancy Services, Thane, India
Background/Purpose: Recent data suggesting the growing problem of medication non-adherence in gout has called for the need to understand the magnitude of the problem as…
Abstract Number: 211 • 2013 ACR/ARHP Annual Meeting
The Economic Burden Of Gout: A Systematic Review Of Direct and Indirect Costs
Sharan Rai¹, Aliya Haji², Lindsay C Burns³ and Hyon Choi^4,5, ¹Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The prevalence of gout, an excruciating and disabling joint disease, has been increasing in recent decades such that it now constitutes the most…
Abstract Number: 212 • 2013 ACR/ARHP Annual Meeting
Dual-Energy Computed Tomography for Monitoring of Urate Deposition in Tophaceous Gout: A Prospective Longitudinal Study Examining Sensitivity to Change
Ashwin Rajan¹, Opetaia Aati², Ramanamma Kalluru³, Gregory Gamble², Anne Horne², Anthony Doyle¹, Fiona M. McQueen⁴ and Nicola Dalbeth⁵, ¹University of Auckland, Auckland, New Zealand, ²Department of Medicine, University of Auckland, Auckland, New Zealand, ³Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, ⁴Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ⁵Medicine, University of Auckland, Auckland, New Zealand
Background/Purpose: Dual-energy computed tomography (DECT) is an advanced imaging method with potential for monitoring urate deposition in patients with gout. The aim of this prospective…
Abstract Number: 213 • 2013 ACR/ARHP Annual Meeting
Digital Tomosynthesis for Measurement of Bone Erosion in Gout: Comparison With Computed Tomography
Nicola Dalbeth¹, Anthony Doyle², Mark Roger³, Angela Gao⁴ and Fiona M. McQueen⁵, ¹Medicine, University of Auckland, Auckland, New Zealand, ²University of Auckland, Auckland, New Zealand, ³Department of Radiology, Auckland District Health Board, Auckland, New Zealand, ⁴Radiology, Auckland District Health Board, Auckland, New Zealand, ⁵Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
Background/Purpose: Digital tomosynthesis is a recently developed imaging method in which multiple projected images obtained at different angles are collected with a digital detector. These…
Abstract Number: 214 • 2013 ACR/ARHP Annual Meeting
Use Of Dual-Energy Computed Tomography In Evaluation Of Axial Gout
Kristin Logee¹, Ranadeep Mandhadi¹, William Traverse² and Santhanam Lakshminarayanan³, ¹Rheumatology, University of Connecticut, Farmington, CT, ²Rheumatology, Saint Francis Hospital and Medical Center, Hartford, CT, ³Dept of Med/Div Rheum Diseases, University of Connecticut School of Medicine, Farmington, CT
Background/Purpose: Axial (spinal) involvement has become increasingly recognized as a potential manifestation of gouty arthritis. The presentation can vary widely from mild, asymptomatic disease to…
Abstract Number: 215 • 2013 ACR/ARHP Annual Meeting
Relationship Between Structural Joint Damage and Urate Deposition In Gout: A Site-By-Site Analysis Using Plain Radiography and Dual Energy Computed Tomography
Nicola Dalbeth¹, Opetaia Aati², Ramanamma Kalluru³, Anne Horne², Anthony Doyle⁴ and Fiona M. McQueen⁵, ¹Medicine, University of Auckland, Auckland, New Zealand, ²Department of Medicine, University of Auckland, Auckland, New Zealand, ³Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, ⁴University of Auckland, Auckland, New Zealand, ⁵Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
Background/Purpose: Structural joint damage, including erosion, joint space narrowing (JSN) and new bone formation (NBF), is frequently observed in patients with tophaceous gout. Although imaging…
Abstract Number: 217 • 2013 ACR/ARHP Annual Meeting
Clinical Value Of ¹⁸f-Fluoro-Dexoxyglucose Positron Emission Tomography In Patients With Adult-Onset Still’s Disease
Hiroyuki Yamashita¹, Kazuo Kubota², Yuko Takahashi¹, Hiroshi Kaneko¹, Toshikazu Kano¹ and Akio Mimori¹, ¹Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan, ²Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan
AbstractBackground/Purpose: The aim of this study was to assess the usefulness of 18F-fluoro-dexoxyglucose positron emission tomography/Computed tomography (18F-FDG PET/CT) for the diagnosis or the evaluation…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].